Latest News for: 1808

Edit

BioInvent's anti TNFR2 antibody BI 1808 showcased at the 16th Annual T Cell Lymphoma Forum (BioInvent International AB)

Public Technologies 21 Mar 2025
2025-03-21 08.00.00 CET BioInvent International AB - Investor News BioInvent's anti-TNFR2 antibody BI-1808 showcased at the 16th Annual T-Cell Lymphoma Forum ... BI-1808, a first-in-class ... About BI-1808.
Edit

BioInvent Receives FDA Orphan Drug Designation for BI 1808 for the Treatment of T cell Lymphoma (BioInvent International AB)

Public Technologies 20 Mar 2025
2025-03-20 08.00.00 CET BioInvent International AB - Investor News BioInvent Receives FDA Orphan Drug Designation for BI-1808 for the Treatment of T-cell Lymphoma ... About BI-1808 ... BI-1808 is a ...
  • 1

Article Search

tools
×
×
×
×